ClinVar Miner

Submissions for variant NM_001182.5(ALDH7A1):c.141_142insA (p.Arg48fs)

dbSNP: rs1296037862
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Illumina Laboratory Services, Illumina RCV000778747 SCV000915107 uncertain significance Pyridoxine-dependent epilepsy 2017-09-07 criteria provided, single submitter clinical testing The ALDH7A1 c.141_142insA (p.Arg48ThrfsTer9) variant results in a frameshift and is predicted to result in premature termination of the protein. It was observed by ICSL as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018) and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score for this variant, it could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change. No publications were found based on this search. Due to the potential impact of frameshift variants and the lack of clarifying evidence, this variant is classified as a variant of unknown significance but suspicious for pathogenicity for pyridoxine-dependent epilepsy.
CeGaT Center for Human Genetics Tuebingen RCV001090283 SCV001245731 pathogenic not provided 2017-04-01 criteria provided, single submitter clinical testing
Labcorp Genetics (formerly Invitae), Labcorp RCV000778747 SCV001401952 pathogenic Pyridoxine-dependent epilepsy 2023-03-01 criteria provided, single submitter clinical testing This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with pyridoxine-dependent epilepsy (PMID: 19294602). ClinVar contains an entry for this variant (Variation ID: 631954). For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Arg48Thrfs*9) in the ALDH7A1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ALDH7A1 are known to be pathogenic (PMID: 16491085, 20554659).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.